5-(4-Cyclopropyl-1H-imidazol-l-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide

[email protected]
5-(4-Cyclopropyl-1H-imidazol-l-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide
Trade Name
Orphan Indication Pulmonary Arterial Hypertension
USA Market Approval USA
USA Designation Date 2015-01-15 00:00:00
Sponsor Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404
Related Access Program
Pfizer – Pulmonary Arterial Hypertension (PAH) Pfizer – Pulmonary Arterial Hypertension Bayer – Pulmonary arterial hypertension